The first Law Update of 2024 is here, and our first focus of the year spotlights Healthcare and Lifesciences, a sector that is undergoing significant growth and development across the MENA region.
Our focus provides an insight into some of the most important regulatory updates across the region, such as the UAE’s groundbreaking law on the use of human genome, Kuwait’s resolution on nuclear and radioactive materials, the new regulations for healthcare services in Qatar, Egypt’s healthcare regulatory framework, and the impact of the Saudi Civil Transactions Law on the healthcare and life sciences sector … and there is so much more!
Beyond the healthcare pages our lawyers share with you multi-sector insights where you will discover articles on Dubai’s DIFC regulatory framework for startups, Bahrain’s commercial agencies law, and we also shed light on Kuwaiti civil code and the advantages of setting up a joint stock company in Saudi Arabia.Read the full edition
The Saudi Ports Authority had on 9 March 2020 issued Circular No. 37 of 2020 containing the following mandatory orders:
(i) Save for the purposes of evacuation, delivery of goods, and trading – all sea voyages between the Kingdom of Saudi Arabia (the “KSA”) and any of the below countries shall cease:
(g) South Korea;
(h) Syria; and
(i) The United Arab Emirates
(collectively, the “Restricted States”).
(ii) Any person who was in any of the Restricted States within the 14 days immediately prior to his/her arrival in the KSA, shall be not be allowed to enter the KSA
(iii) No seafarer who was in any of the Restricted States within the 14 days immediately prior to his/her arrival in the KSA, shall be permitted to board or disembark from any ship that calls any KSA port.
(iv) No seafarer shall be permitted to board or disembark from any ship that was in any of the Restricted States within the 14 days immediately prior to her arrival in the KSA.